SCHEMBL1911780

SCHEMBL1911780

NS(=O)(=O)c1ccc2[nH]c(-c3ccccc3)cc2c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 6/20 0.70
CA2 P00918 6/20 0.70
CA12 O43570 5/20 0.70
CA9 Q16790 5/20 0.70
CYP19A1 P11511 4/20 0.56
NPC1 O15118 3/20 0.55
RAB9A P51151 3/20 0.55
KDM4E B2RXH2 2/20 0.55
MEN1 O00255 2/20 0.55
MAPT P10636 2/20 0.55
KMT2A Q03164 2/20 0.55
LMNA P02545 2/20 0.55
ALDH1A1 P00352 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
F2 P00734 2/20 0.52
PPARG P37231 1/20 0.51
VCP P55072 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
CA4 P22748 1/20 0.46
CA6 P23280 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19065049 0.88 CA1 (0.70) CA1CA2CA12CA9CYP19A1
SCHEMBL517119 0.84 CYP19A1 (0.56) CA1CA2CA12CA9CYP19A1
SCHEMBL27915152 0.84 CYP19A1 (0.56) CA1CA2CA12CA9CYP19A1
SCHEMBL4147377 0.84 CYP19A1 (0.56) CA1CA2CA12CA9CYP19A1
SCHEMBL516961 0.84 NPC1 (0.59) CA1CA2CA12CA9CYP19A1
SCHEMBL29132395 0.83 CYP19A1 (0.55) CA1CA2CA12CA9CYP19A1
SCHEMBL4158621 0.76 CA12 (0.51) CA1CA2CA12CA9CYP19A1
SCHEMBL12124985 0.75 NPC1 (0.75) CYP19A1NPC1RAB9AKDM4EMEN1
SCHEMBL1465037 0.75 NPC1 (0.64) CA1CA2CA12CA9CYP19A1
SCHEMBL31548558 0.75 NPC1 (0.64) CA1CA2CA12CA9CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2598486-B1 BICYCLIC ACETYL-COA CARBOXYLASE INHIBITORS NOVARTIS AG (CH) 2017-06-28 EP disclosed
WO-2012013716-A1 BICYCLIC ACETYL-COA CARBOXYLASE INHIBITORS NOVARTIS AG (CH) 2012-02-02 WO disclosed